We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RRR:NASDAQRed Rock Resorts, Inc. Analysis

Data as of 2026-04-29 - not real-time

$55.53

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Red Rock Resorts (RRR) is trading at $55.53, just above its near‑term support of $52.12 but below the 20‑day SMA of $55.80, indicating a short‑term bearish bias. The 50‑day and 200‑day SMAs sit higher at $58.02 and $59.26, reinforcing the down‑trend bias on longer time frames. RSI at 45.7 suggests momentum is neutral to slightly bearish, while the MACD line has just crossed above its signal, producing a marginal bullish histogram that may signal a tentative pause. Volume is increasing, which could provide the liquidity needed for a breakout, but the 30‑day volatility of 33% and a beta around 1.0 imply the stock will continue to swing sharply with the market. Market sentiment is extremely greedy (FGI 89.6), and analysts collectively rate the stock as a “buy” with a median price target of $73.5, implying roughly 30% upside.
On the fundamentals side, RRR delivers a solid 67% gross margin and a 31% operating margin, yet profit margins sit at only 9.3% and ROE is a meager 1.1%, reflecting the drag from an enormous debt load. The debt‑to‑equity ratio exceeds 1,000% and total debt ($3.48B) dwarfs cash on hand ($0.14B), raising concerns about balance‑sheet resilience. The stock trades at a forward PE of 17 and a price‑to‑book of 15.5, far above industry averages, which tempers the attractiveness of the current price despite a 1.87% dividend yield and a modest 32% payout ratio. Free cash flow remains positive at $192M, supporting the dividend for now, but the leverage level makes long‑term sustainability questionable. Given the mixed technical picture, strong cash generation, but significant financial risk, we view RRR as undervalued relative to its upside potential, but recommend a cautious stance pending the upcoming earnings release.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Upcoming earnings release could trigger volatility
  • Technical indicators show bearish bias near support
  • High leverage may limit upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus target price implies ~30% upside
  • Positive free cash flow supports dividend and potential debt reduction
  • Improving earnings momentum could lift price toward SMA levels

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong gross and operating margins provide a competitive advantage
  • Industry recovery and strategic asset base in Las Vegas region
  • Potential deleveraging through cash generation enhances sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin9.35%
P/E Ratio17.8
ROE111.30%
ROA9.38%
Debt/Equity1045.93
P/B Ratio15.5
Op. Cash Flow$609.5M
Free Cash Flow$192.8M

Technical Analysis

TrendBearish
RSI45.7
Support$52.12
Resistance$59.08
MA 20$55.80
MA 50$58.02
MA 200$59.26
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Target Price$71.88
Upside/Downside29.43%
GradeUndervalued
TypeBlend
Dividend Yield1.87%

Risk Assessment

Beta1.02
Volatility33.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.